Aston EyeTech Limited – Trademark Portfolio
Entity Type: 99
Aston EyeTech Limited holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EBOX and EYOTO. The owner is based in Birmingham.
Faraday Wharf,
Birmingham B7 4BB , GB
Showing of trademarks Trademarks
Trademark Classifications
Aston EyeTech Limited's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Aston EyeTech Limited have?
Aston EyeTech Limited has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Aston EyeTech Limited file in?
Aston EyeTech Limited files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Aston EyeTech Limited's most well-known trademarks?
Aston EyeTech Limited's registered trademark portfolio includes well-known marks such as EBOX and EYOTO. These are among 3 currently registered trademarks in the portfolio.
What is Aston EyeTech Limited's trademark registration success rate?
Aston EyeTech Limited has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.